A top biotech fund just made a bold move while Celcuity trades near record highs—here’s what they might see coming next.

Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...

Donald Trump's new "Genesis Mission" initiative promises to use artificial intelligence to reinvent how science is done, in a ...

Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...

Prognostications that the AI bubble is grossly overbought have been increasing. The fact that the Magnificent 7 AI stocks, ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

In the biotech field, alongside the widely recognized industry giants, some relatively smaller companies focused on specific niches are also demonstrating considerable potential through solid R& ...

Shares of biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) have staged a notable rebound, with a single-day surge exceeding 5%, drawing market attention. This rally interrupts a nearly ...